Annual CFO
-$21.27 M
-$5.16 M-32.03%
31 December 2023
Summary:
AIM ImmunoTech annual cash flow from operations is currently -$21.27 million, with the most recent change of -$5.16 million (-32.03%) on 31 December 2023. During the last 3 years, it has fallen by -$7.30 million (-52.29%). AIM annual CFO is now -1019.32% below its all-time high of -$1.90 million, reached on 31 December 1995.AIM Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$3.11 M
-$102.00 K-3.39%
30 September 2024
Summary:
AIM ImmunoTech quarterly cash flow from operations is currently -$3.11 million, with the most recent change of -$102.00 thousand (-3.39%) on 30 September 2024. Over the past year, it has increased by +$6.65 million (+68.13%). AIM quarterly CFO is now -483.49% below its all-time high of -$533.00 thousand, reached on 30 June 2003.AIM Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$20.69 M
+$2.56 M+11.01%
30 September 2024
Summary:
AIM ImmunoTech TTM cash flow from operations is currently -$20.69 million, with the most recent change of +$2.56 million (+11.01%) on 30 September 2024. Over the past year, it has increased by +$576.00 thousand (+2.71%). AIM TTM CFO is now -666.33% below its all-time high of -$2.70 million, reached on 31 March 1996.AIM TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AIM Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +68.1% | +2.7% |
| 3 y3 years | -52.3% | +45.9% | -48.2% |
| 5 y5 years | -134.6% | -35.9% | -128.2% |
AIM Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -52.3% | at low | -44.1% | +68.1% | -51.3% | +11.0% |
| 5 y | 5 years | -134.6% | at low | -143.9% | +68.1% | -128.2% | +11.0% |
| alltime | all time | -1019.3% | at low | -483.5% | +68.1% | -666.3% | +11.0% |
AIM ImmunoTech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.11 M(+3.4%) | -$20.69 M(-11.0%) |
| June 2024 | - | -$3.01 M(-37.5%) | -$23.25 M(+3.8%) |
| Mar 2024 | - | -$4.82 M(-50.7%) | -$22.40 M(+5.3%) |
| Dec 2023 | -$21.27 M(+32.0%) | -$9.76 M(+72.1%) | -$21.27 M(+21.0%) |
| Sept 2023 | - | -$5.67 M(+162.8%) | -$17.58 M(+4.2%) |
| June 2023 | - | -$2.16 M(-41.4%) | -$16.88 M(-0.9%) |
| Mar 2023 | - | -$3.68 M(-39.4%) | -$17.03 M(+5.7%) |
| Dec 2022 | -$16.11 M(+15.3%) | -$6.07 M(+22.2%) | -$16.11 M(+2.1%) |
| Sept 2022 | - | -$4.97 M(+114.8%) | -$15.78 M(+10.6%) |
| June 2022 | - | -$2.31 M(-16.1%) | -$14.27 M(+4.4%) |
| Mar 2022 | - | -$2.76 M(-52.0%) | -$13.68 M(-2.1%) |
| Dec 2021 | -$13.96 M(+34.7%) | -$5.75 M(+66.2%) | -$13.96 M(+26.1%) |
| Sept 2021 | - | -$3.46 M(+101.2%) | -$11.07 M(+4.4%) |
| June 2021 | - | -$1.72 M(-43.6%) | -$10.61 M(+4.4%) |
| Mar 2021 | - | -$3.04 M(+6.7%) | -$10.16 M(-2.0%) |
| Dec 2020 | -$10.37 M(+14.3%) | -$2.85 M(-4.5%) | -$10.37 M(+5.8%) |
| Sept 2020 | - | -$2.99 M(+134.4%) | -$9.80 M(+4.8%) |
| June 2020 | - | -$1.27 M(-60.8%) | -$9.36 M(-13.8%) |
| Mar 2020 | - | -$3.25 M(+42.0%) | -$10.86 M(+19.8%) |
| Dec 2019 | -$9.07 M(-14.8%) | -$2.29 M(-10.0%) | -$9.07 M(-1.4%) |
| Sept 2019 | - | -$2.54 M(-8.4%) | -$9.20 M(-4.5%) |
| June 2019 | - | -$2.78 M(+90.6%) | -$9.63 M(+0.8%) |
| Mar 2019 | - | -$1.46 M(-39.8%) | -$9.55 M(-10.2%) |
| Dec 2018 | -$10.64 M(+34.0%) | -$2.42 M(-18.7%) | -$10.64 M(+18.5%) |
| Sept 2018 | - | -$2.98 M(+10.1%) | -$8.98 M(+13.9%) |
| June 2018 | - | -$2.70 M(+6.3%) | -$7.88 M(+5.3%) |
| Mar 2018 | - | -$2.54 M(+234.5%) | -$7.49 M(-5.7%) |
| Dec 2017 | -$7.94 M(+7.6%) | -$760.00 K(-59.6%) | -$7.94 M(-14.5%) |
| Sept 2017 | - | -$1.88 M(-18.5%) | -$9.28 M(-10.6%) |
| June 2017 | - | -$2.31 M(-22.9%) | -$10.39 M(+11.4%) |
| Mar 2017 | - | -$2.99 M(+42.4%) | -$9.33 M(+26.4%) |
| Dec 2016 | -$7.38 M(-54.0%) | -$2.10 M(-29.6%) | -$7.38 M(-14.1%) |
| Sept 2016 | - | -$2.99 M(+139.1%) | -$8.59 M(-5.7%) |
| June 2016 | - | -$1.25 M(+19.8%) | -$9.11 M(-29.1%) |
| Mar 2016 | - | -$1.04 M(-68.5%) | -$12.84 M(-20.0%) |
| Dec 2015 | -$16.05 M(+15.0%) | -$3.31 M(-5.4%) | -$16.05 M(-4.3%) |
| Sept 2015 | - | -$3.50 M(-29.7%) | -$16.77 M(-1.3%) |
| June 2015 | - | -$4.98 M(+17.0%) | -$17.00 M(+10.9%) |
| Mar 2015 | - | -$4.26 M(+5.6%) | -$15.33 M(+9.8%) |
| Dec 2014 | -$13.96 M(-17.4%) | -$4.03 M(+8.3%) | -$13.96 M(+5.9%) |
| Sept 2014 | - | -$3.73 M(+12.5%) | -$13.19 M(-2.2%) |
| June 2014 | - | -$3.31 M(+14.4%) | -$13.48 M(-3.3%) |
| Mar 2014 | - | -$2.90 M(-11.1%) | -$13.95 M(-17.5%) |
| Dec 2013 | -$16.90 M(+28.7%) | -$3.25 M(-19.0%) | -$16.90 M(-9.1%) |
| Sept 2013 | - | -$4.02 M(+6.3%) | -$18.60 M(+7.6%) |
| June 2013 | - | -$3.78 M(-35.4%) | -$17.29 M(-0.2%) |
| Mar 2013 | - | -$5.85 M(+18.1%) | -$17.32 M(+31.9%) |
| Dec 2012 | -$13.14 M(+30.1%) | -$4.96 M(+83.3%) | -$13.14 M(+17.3%) |
| Sept 2012 | - | -$2.70 M(-29.1%) | -$11.20 M(+4.0%) |
| June 2012 | - | -$3.81 M(+129.0%) | -$10.77 M(+8.3%) |
| Mar 2012 | - | -$1.67 M(-44.9%) | -$9.94 M(-1.5%) |
| Dec 2011 | -$10.10 M(-15.1%) | -$3.02 M(+33.0%) | -$10.10 M(+13.6%) |
| Sept 2011 | - | -$2.27 M(-23.9%) | -$8.89 M(-4.4%) |
| June 2011 | - | -$2.98 M(+64.1%) | -$9.30 M(-4.9%) |
| Mar 2011 | - | -$1.82 M(+0.1%) | -$9.78 M(-17.7%) |
| Dec 2010 | -$11.89 M | -$1.82 M(-32.3%) | -$11.89 M(-6.4%) |
| Sept 2010 | - | -$2.68 M(-22.6%) | -$12.70 M(+1.2%) |
| June 2010 | - | -$3.46 M(-11.8%) | -$12.56 M(+6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$3.92 M(+49.1%) | -$11.80 M(+26.9%) |
| Dec 2009 | -$9.30 M(-0.7%) | -$2.63 M(+3.8%) | -$9.30 M(+13.8%) |
| Sept 2009 | - | -$2.54 M(-6.2%) | -$8.17 M(-0.4%) |
| June 2009 | - | -$2.71 M(+90.0%) | -$8.21 M(+2.9%) |
| Mar 2009 | - | -$1.42 M(-5.6%) | -$7.98 M(-14.8%) |
| Dec 2008 | -$9.36 M(-38.1%) | -$1.51 M(-41.3%) | -$9.36 M(-14.6%) |
| Sept 2008 | - | -$2.57 M(+3.9%) | -$10.96 M(-12.8%) |
| June 2008 | - | -$2.47 M(-11.8%) | -$12.56 M(-4.0%) |
| Mar 2008 | - | -$2.81 M(-9.6%) | -$13.08 M(-13.5%) |
| Dec 2007 | -$15.11 M(+9.9%) | -$3.10 M(-25.6%) | -$15.11 M(-8.0%) |
| Sept 2007 | - | -$4.17 M(+39.3%) | -$16.43 M(+7.6%) |
| June 2007 | - | -$3.00 M(-38.1%) | -$15.26 M(-2.7%) |
| Mar 2007 | - | -$4.84 M(+9.5%) | -$15.69 M(+14.1%) |
| Dec 2006 | -$13.75 M(+90.1%) | -$4.42 M(+46.9%) | -$13.75 M(+21.9%) |
| Sept 2006 | - | -$3.01 M(-12.1%) | -$11.28 M(+16.4%) |
| June 2006 | - | -$3.42 M(+18.2%) | -$9.69 M(+19.9%) |
| Mar 2006 | - | -$2.90 M(+48.7%) | -$8.08 M(+11.7%) |
| Dec 2005 | -$7.23 M(-0.1%) | -$1.95 M(+37.4%) | -$7.23 M(-1.0%) |
| Sept 2005 | - | -$1.42 M(-21.8%) | -$7.30 M(+1.0%) |
| June 2005 | - | -$1.81 M(-11.6%) | -$7.23 M(-4.4%) |
| Mar 2005 | - | -$2.05 M(+1.4%) | -$7.57 M(+4.5%) |
| Dec 2004 | -$7.24 M(+3.1%) | -$2.02 M(+50.2%) | -$7.24 M(+9.0%) |
| Sept 2004 | - | -$1.35 M(-37.4%) | -$6.64 M(-23.4%) |
| June 2004 | - | -$2.15 M(+24.9%) | -$8.67 M(+22.9%) |
| Mar 2004 | - | -$1.72 M(+21.0%) | -$7.05 M(+0.4%) |
| Dec 2003 | -$7.02 M(+9.6%) | -$1.42 M(-57.8%) | -$7.02 M(-0.8%) |
| Sept 2003 | - | -$3.37 M(+533.0%) | -$7.08 M(+38.0%) |
| June 2003 | - | -$533.00 K(-68.5%) | -$5.13 M(-12.3%) |
| Mar 2003 | - | -$1.69 M(+14.2%) | -$5.85 M(-8.7%) |
| Dec 2002 | -$6.41 M(-12.0%) | -$1.48 M(+4.1%) | -$6.41 M(-1.0%) |
| Sept 2002 | - | -$1.42 M(+13.7%) | -$6.47 M(-2.3%) |
| June 2002 | - | -$1.25 M(-44.4%) | -$6.62 M(-9.8%) |
| Mar 2002 | - | -$2.25 M(+45.8%) | -$7.34 M(+0.9%) |
| Dec 2001 | -$7.28 M(-9.8%) | -$1.54 M(-2.1%) | -$7.28 M(-2.0%) |
| Sept 2001 | - | -$1.58 M(-20.0%) | -$7.43 M(-4.5%) |
| June 2001 | - | -$1.97 M(-10.0%) | -$7.78 M(+0.6%) |
| Mar 2001 | - | -$2.19 M(+29.2%) | -$7.73 M(-4.2%) |
| Dec 2000 | -$8.07 M(+15.5%) | -$1.69 M(-12.0%) | -$8.07 M(-2.4%) |
| Sept 2000 | - | -$1.93 M(+0.1%) | -$8.27 M(+5.4%) |
| June 2000 | - | -$1.92 M(-24.0%) | -$7.84 M(+2.9%) |
| Mar 2000 | - | -$2.53 M(+33.9%) | -$7.62 M(+9.0%) |
| Dec 1999 | -$6.99 M(+18.5%) | -$1.89 M(+26.0%) | -$6.99 M(-4.2%) |
| Sept 1999 | - | -$1.50 M(-11.8%) | -$7.30 M(-1.4%) |
| June 1999 | - | -$1.70 M(-10.5%) | -$7.40 M(+8.8%) |
| Mar 1999 | - | -$1.90 M(-13.6%) | -$6.80 M(+15.3%) |
| Dec 1998 | -$5.90 M(+28.3%) | -$2.20 M(+37.5%) | -$5.90 M(+13.5%) |
| Sept 1998 | - | -$1.60 M(+45.5%) | -$5.20 M(+15.6%) |
| June 1998 | - | -$1.10 M(+10.0%) | -$4.50 M(0.0%) |
| Mar 1998 | - | -$1.00 M(-33.3%) | -$4.50 M(-2.2%) |
| Dec 1997 | -$4.60 M(-24.6%) | -$1.50 M(+66.7%) | -$4.60 M(+7.0%) |
| Sept 1997 | - | -$900.00 K(-18.2%) | -$4.30 M(-6.5%) |
| June 1997 | - | -$1.10 M(0.0%) | -$4.60 M(+2.2%) |
| Mar 1997 | - | -$1.10 M(-8.3%) | -$4.50 M(-26.2%) |
| Dec 1996 | -$6.10 M(+221.1%) | -$1.20 M(0.0%) | -$6.10 M(+24.5%) |
| Sept 1996 | - | -$1.20 M(+20.0%) | -$4.90 M(+32.4%) |
| June 1996 | - | -$1.00 M(-63.0%) | -$3.70 M(+37.0%) |
| Mar 1996 | - | -$2.70 M | -$2.70 M |
| Dec 1995 | -$1.90 M | - | - |
FAQ
- What is AIM ImmunoTech annual cash flow from operations?
- What is the all time high annual CFO for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly cash flow from operations?
- What is the all time high quarterly CFO for AIM ImmunoTech?
- What is AIM ImmunoTech quarterly CFO year-on-year change?
- What is AIM ImmunoTech TTM cash flow from operations?
- What is the all time high TTM CFO for AIM ImmunoTech?
- What is AIM ImmunoTech TTM CFO year-on-year change?
What is AIM ImmunoTech annual cash flow from operations?
The current annual CFO of AIM is -$21.27 M
What is the all time high annual CFO for AIM ImmunoTech?
AIM ImmunoTech all-time high annual cash flow from operations is -$1.90 M
What is AIM ImmunoTech quarterly cash flow from operations?
The current quarterly CFO of AIM is -$3.11 M
What is the all time high quarterly CFO for AIM ImmunoTech?
AIM ImmunoTech all-time high quarterly cash flow from operations is -$533.00 K
What is AIM ImmunoTech quarterly CFO year-on-year change?
Over the past year, AIM quarterly cash flow from operations has changed by +$6.65 M (+68.13%)
What is AIM ImmunoTech TTM cash flow from operations?
The current TTM CFO of AIM is -$20.69 M
What is the all time high TTM CFO for AIM ImmunoTech?
AIM ImmunoTech all-time high TTM cash flow from operations is -$2.70 M
What is AIM ImmunoTech TTM CFO year-on-year change?
Over the past year, AIM TTM cash flow from operations has changed by +$576.00 K (+2.71%)